Literature DB >> 11980399

[Antimalarial guidelines and therapy practices of the population of Bouake, Ivory Coast].

J Dossou-Yovo1, K Amalaman, P Carnevale.   

Abstract

This survey of 162 households in the city of Bouaké, Côte d'Ivoire was undertaken to study the behavior of the population in diagnosing and treating malaria. Findings indicate that awareness of symptoms and ability to evaluate the severity of malaria is high. In most cases, mild malaria is treated at home. In case of presumptive diagnosis of malaria, 87.6% of households undertake self-treatment, 9.3% seek institutional healthcare, 1.2% go to traditional healers, and 1.9% use traditional remedies. The most frequent drug for primary treatment is chloroquine (68.3%) which is generally obtained from pharmacies (98.8%). However, proper dosages are rarely used. If primary treatment fails, behavior is complex depending on the estimated severity of disease. Although many causes of malaria are mentioned, most people implicate mosquitoes (75.6%). In 95.1% of households surveyed, chloroquine prophylaxis was used for newborns. Most households (89.5%) practice mosquito bite protection but use of mosquito nets is low (4.9%). These results showing the preference for family-based management suggest that informational campaigns are needed to promote effective and consistent home treatment. Education is also needed to increase knowledge about mosquito nets and insecticides.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11980399

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  2 in total

1.  Treatment-seeking Paths in the Management of Severe Malaria in Children under 15 Years of Age Treated in Reference Hospitals of Kinshasa, Democratic Republic of Congo.

Authors:  Félicien Ilunga-Ilunga; Alain Levêque; Léon Okenge Ngongo; Samia Laokri; Michèle Dramaix
Journal:  Trop Med Health       Date:  2014-10-16

2.  Social perceptions of malaria and diagnostic-driven malaria treatment in Burkina Faso.

Authors:  Orokia Traore; Awa Ouedraogo; Moussa Compaore; Kader Nikiema; Abdoulaye Zombre; Martin Kiendrebeogo; Bertrand Blankert; Pierre Duez
Journal:  Heliyon       Date:  2021-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.